Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Fresenius SE & Co. KGaA buy MBU

Start price
€28.56
10.05.24 / 50%
Target price
-
10.06.24
Performance (%)
5.57%
End price
€30.15
11.06.24
Summary
This prediction ended on 11.06.24 with a price of €30.15. With a performance of 5.57%, the BUY prediction by MBU for Fresenius SE & Co. KGaA closed with a slight gain. MBU has 50% into this prediction

Fresenius is a German healthcare company listed on the Frankfurt and New York stock exchanges under the symbol FSNUF. The company is primarily engaged in the production and distribution of medical devices, pharmaceuticals, and services related to renal dialysis, critical care, and hospital operations. With over 290,000 employees and operations in more than 100 countries, Fresenius is one of the largest healthcare providers in the world. The company has experienced steady growth over the years, driven by its innovative product portfolio, strategic acquisitions, and a focus on operational efficiency.

Performance without dividends (%)
Name 1w 1m
Fresenius SE & Co. KGaA 4.304% 4.304%
iShares Core DAX® 1.395% -0.696%
iShares Nasdaq 100 2.287% 7.501%
iShares Nikkei 225® 1.617% 2.769%
iShares S&P 500 0.659% 4.280%

Comments by MBU for this prediction

In the thread Trading Fresenius SE & Co. KGaA
Prediction Buy
Perf. (%) 5.57%
Target price
Change
Ends at 10.06.24

Die von MBU gewählte maximale Laufzeit wurde überschritten